Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free NKGNW Stock Alerts

NKGen Biotech (NKGNW) Competitors

$0.0003 0.00 (0.00%)
As of 05/29/2026
Compare

NKGNW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy NKGen Biotech stock or one of its competitors? MarketBeat compares NKGen Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NKGen Biotech include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does NKGen Biotech compare to 60 Degrees Pharmaceuticals?

NKGen Biotech (NASDAQ:NKGNW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than NKGen Biotech. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for NKGen Biotech. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat NKGen Biotech's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
60 Degrees Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats NKGen Biotech on 3 of the 3 factors compared between the two stocks.

How does NKGen Biotech compare to Alpha Tau Medical?

NKGen Biotech (NASDAQ:NKGNW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 2 mentions for Alpha Tau Medical and 0 mentions for NKGen Biotech. Alpha Tau Medical's average media sentiment score of 0.43 beat NKGen Biotech's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
Alpha Tau Medical Neutral

Summary

Alpha Tau Medical beats NKGen Biotech on 2 of the 2 factors compared between the two stocks.

How does NKGen Biotech compare to Apollomics?

Apollomics (NASDAQ:APLMW) and NKGen Biotech (NASDAQ:NKGNW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
NKGen BiotechN/AN/AN/AN/AN/A

In the previous week, Apollomics had 1 more articles in the media than NKGen Biotech. MarketBeat recorded 1 mentions for Apollomics and 0 mentions for NKGen Biotech. Apollomics' average media sentiment score of 1.87 beat NKGen Biotech's score of 0.00 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
NKGen Biotech Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
NKGen Biotech N/A N/A N/A

Summary

Apollomics beats NKGen Biotech on 3 of the 3 factors compared between the two stocks.

How does NKGen Biotech compare to BioVie?

NKGen Biotech (NASDAQ:NKGNW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

In the previous week, BioVie had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 2 mentions for BioVie and 0 mentions for NKGen Biotech. BioVie's average media sentiment score of 0.44 beat NKGen Biotech's score of 0.00 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
BioVie N/A N/A N/A

Summary

BioVie beats NKGen Biotech on 2 of the 2 factors compared between the two stocks.

How does NKGen Biotech compare to Cardio Diagnostics?

NKGen Biotech (NASDAQ:NKGNW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than NKGen Biotech. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for NKGen Biotech. Cardio Diagnostics' average media sentiment score of 1.87 beat NKGen Biotech's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
NKGen Biotech Neutral
Cardio Diagnostics Very Positive

Summary

Cardio Diagnostics beats NKGen Biotech on 3 of the 3 factors compared between the two stocks.

Get NKGen Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKGNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NKGNW vs. The Competition

Export
MetricNKGen BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$388.04M$55.95B$30.05B
Dividend YieldN/A3.86%2.69%5.33%
P/E RatioN/A3.0721.6326.27
Price / SalesN/A7,203.00565.57116.86
Price / CashN/A13.1343.2256.84
Price / BookN/A85.4810.557.30
Net IncomeN/A-$96.07M$3.56B$337.27M
7 Day PerformanceN/A2.02%2.85%3.58%
1 Month PerformanceN/A2.87%4.59%5.71%
1 Year PerformanceN/A96.23%37.62%39.70%

NKGen Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NKGNW
NKGen Biotech
N/A$0.00
flat		N/AN/A$0.00N/AN/A63
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
+29.3%		N/A-36.0%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.47
-14.2%		N/A+1,208.4%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+11.0%		N/A-29.8%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.33
+7.1%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NKGNW) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel